John Shelton

414 total citations
25 papers, 333 citations indexed

About

John Shelton is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, John Shelton has authored 25 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in John Shelton's work include Hormonal Regulation and Hypertension (10 papers), Electrolyte and hormonal disorders (8 papers) and Ion Transport and Channel Regulation (3 papers). John Shelton is often cited by papers focused on Hormonal Regulation and Hypertension (10 papers), Electrolyte and hormonal disorders (8 papers) and Ion Transport and Channel Regulation (3 papers). John Shelton collaborates with scholars based in United Kingdom, Sri Lanka and United States. John Shelton's co-authors include Lawrence E. Ramsay, I. Harrison, Pamela Scott, LE Ramsay, J. Hettiarachchi, GT McInnes, R. F. Palmer, Gordon T. McInnes, Chamara Dalugama and Michael R. Scott and has published in prestigious journals such as British Journal of Pharmacology, Annals of the Rheumatic Diseases and Journal of Pharmaceutical Sciences.

In The Last Decade

John Shelton

24 papers receiving 284 citations

Peers

John Shelton

EDM

PRM

PPCH

PHARM

Robert M. Stote United States

K. Koch Germany

P. De Schepper Belgium

Jack A. Maggiore United States

V. Malerczyk Germany

Hannu Sundquist Finland

Anders Rosén Sweden

P. Anderson Sweden

I. Scaricabarozzi Italy

Thomas J. Comstock United States

Robert M. Stote United States

John Shelton

93 ×0.9

EDM

118 ×1.4

PRM

122 ×1.8

77 ×1.6

PPCH

61 ×1.3

PHARM

Citations per year, relative to John Shelton John Shelton (= 1×) peers Robert M. Stote

Countries citing papers authored by John Shelton

Since Specialization

Citations

This map shows the geographic impact of John Shelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Shelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Shelton more than expected).

Fields of papers citing papers by John Shelton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Shelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Shelton. The network helps show where John Shelton may publish in the future.

Co-authorship network of co-authors of John Shelton

This figure shows the co-authorship network connecting the top 25 collaborators of John Shelton. A scholar is included among the top collaborators of John Shelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Shelton. John Shelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shelton, John, et al.. (2024). A traumatic arteriovenous fistula causing venous insufficiency. Journal of Surgical Case Reports. 2024(8). rjae535–rjae535.

Shelton, John, et al.. (2021). Hemorrhagic Cholecystitis: A Rare Cause of Melena. Cureus. 13(7). e16385–e16385. 1 indexed citations

Shelton, John, et al.. (2021). A Case Report. International Journal of Surgery Case Reports. 86(C). 106350–106350. 1 indexed citations

Shelton, John, et al.. (2021). Minimally invasive management of massive giant hydronephrosis in tertiary care centre Northern Sri Lanka. International Journal of Surgery Case Reports. 88(C). 106514–106514. 3 indexed citations

Dalugama, Chamara, et al.. (2018). Dengue fever complicated with Guillain-Barré syndrome: a case report and review of the literature. Journal of Medical Case Reports. 12(1). 137–137. 22 indexed citations

McInnes, Gordon T., et al.. (1986). Effect of simple short term dietary control on urine electrolyte excretion in normal men. Clinical Science. 71(1). 125–128. 2 indexed citations

McInnes, Gordon T., et al.. (1982). Dose-response relationships for spironolactone at steady state. Clinical Pharmacology & Therapeutics. 31(3). 317–323. 5 indexed citations

McInnes, Gordon T., et al.. (1982). Effect of Micronization on the Bioavailability and Pharmacologic Activity of Spironolactone. The Journal of Clinical Pharmacology. 22(8-9). 410–417. 25 indexed citations

Mclnnes, Gordon T., John Shelton, & I. Harrison. (1981). Steady-state relative potency of aldosterone antagonists: Spironolactone and prorenoate. Clinical Pharmacology & Therapeutics. 29(5). 679–686. 4 indexed citations

10.

McInnes, Gordon T., et al.. (1981). Bioassay of a new aldosterone antagonist and evaluation of a simple method of quantitative comparison. Clinical Pharmacology & Therapeutics. 30(2). 218–225. 3 indexed citations

11.

Stafford, James E., John Shelton, R. F. Palmer, et al.. (1979). Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate. Contraception. 19(2). 119–127. 12 indexed citations

12.

Ramsay, LE, GT McInnes, J. Hettiarachchi, John Shelton, & Pamela Scott. (1978). Bumetanide and frusemide: a comparison of dose‐response curves in healthy men.. British Journal of Clinical Pharmacology. 5(3). 243–247. 39 indexed citations

13.

Ramsay, Lawrence E., et al.. (1978). ENDOCRINE EFFECTS OF SPIRONOLACTONE IN MAN. Clinical Endocrinology. 9(5). 389–399. 19 indexed citations

14.

Ramsay, Lawrence E., et al.. (1977). Spironolactone and canrenoate‐K: Relative potency at steady state. Clinical Pharmacology & Therapeutics. 21(5). 602–609. 29 indexed citations

15.

Hettiarachchi, J., GT McInnes, LE Ramsay, Pamela Scott, & John Shelton. (1977). Bumetanide and frusemide: qualitative differences [proceedings]. British Journal of Clinical Pharmacology. 4(5). 644P–644P. 6 indexed citations

16.

Clarke, Julie M., et al.. (1977). Factors Influencing Comparative Bioavailability of Spironolactone Tablets. Journal of Pharmaceutical Sciences. 66(10). 1429–1432. 24 indexed citations

17.

Ramsay, Lawrence E., et al.. (1976). Spironolactone and potassium canrenoate in normal man. Clinical Pharmacology & Therapeutics. 20(2). 167–177. 37 indexed citations

18.

Gow, James G., et al.. (1976). Comparison of Hydrophilic Polymer‐coated Latex, Uncoated Latex and PVC Indwelling Balloon Catheters in the Prevention of Urinary Infection. British Journal of Urology. 48(3). 285–291. 12 indexed citations

19.

Branch, Robert A., et al.. (1976). Furosemide and bumetanide: A study of responses in normal English and German subjects. Clinical Pharmacology & Therapeutics. 19(5part1). 538–545. 19 indexed citations

20.

Ramsay, Lawrence E., et al.. (1975). Relative potency of prorenoate and spironolactone in normal man. Clinical Pharmacology & Therapeutics. 18(4). 391–400. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact